The forecast for hospital discharges for malignant neoplasm of the prostate in Germany indicates a steady increase from 273.8 per hundred thousand persons in 2024 to 277.9 by 2028. Compared to the actual figure from 2023, the data shows a gradual annual rise.
Year-on-year variation analysis reveals a marginal growth each year, with 0.4% from 2024 to 2025, 0.36% from 2025 to 2026, 0.36% from 2026 to 2027, and 0.32% from 2027 to 2028. The last CAGR over the five-year forecast period stands at 0.35%.
Future trends to watch for include advancements in early detection and treatment methods, which could impact hospital discharge rates. Moreover, demographic changes such as an aging population might elevate incidence rates, warranting close monitoring.
